Press

GLOBAL POINT-OF-CARE TESTING MARKETS FORECASTED TO GROW TO OVER $18.7 BILLION BY 2011

HUNTINGTON BEACH, Calif.-July 2007--(BUSINESS WIRE)--According to a new InteLab Corporation industry report distributed by Life Science Intelligence (LSI), the global point-of-care (POC) testing market will experience dramatic growth from $10.3 billion in 2005 to $18.7 billion by 2011. The new report, "Worldwide Markets and Emerging Technologies for Point-of-Care Testing," provides a detailed global analysis of the patients, procedures, technologies, and companies driving growth and innovation in the POC testing markets. The report segments the market into three primary areas including hospital bedside testing products, home and self-testing products, and physician's office lab products. Several factors driving growth are analyzed including physician demands for more efficient testing approaches, availability of new biosensor technologies and computers systems, and an increased adoption of self-testing products by individuals. The study also discusses the significant and growing demand for diagnostic technologies that can allow more rapid and effective diagnosis and triage, and that lead to improved patient outcomes and reduced health care costs.

The global market study contains 429 pages, 124 exhibits, and coverage of nearly 100 competitors including Abaxis, Abbott, Accumetrics, Adaltis, Axis-Shield, Bayer Diagnostics/Siemens Medical, Beckman Coulter, BD, Biosite, Cepheid, Cholestech, Dexcom, Helena Labs, Hemocue, Hemosense, Thoratec, Inverness Medical Innovations, Medtronic Blood Management, Menarini Diagnostics, Nanogen, OraSure Technologies, Ortho Clinical Diagnostics/LifeScan, Phamatech, Princeton BioMeditech, Qualigen, Quidel, Radiometer, Response Biomedical, Roche Diagnostics, and Spectral Diagnostics.

Key Topics

· Trends in the global clinical diagnostics market and market analysis by segment · Factors driving growth in point-of-care testing

· Hospital POC testing market analysis, including critical care testing, bedside whole blood glucose monitoring, rapid tests, POC coagulation testing, POC cardiac markers, and drugs of abuse rapid tests

· Self-testing market assessment, including whole blood glucose monitoring, coagulation self-testing, pregnancy and fertility testing, home infectious disease and drugs of abuse testing, and home cholesterol testing

· Physician's office laboratory market analysis by segment

· Current and Forecast Market Size, Pricing Trends, and Analysis of Competitive Factors

· Key business transactions, competitor strategies, and technology portfolio analysis

Additional details at http://www.lifescienceintelligence.com/point-of-care.php or by calling 714 847 3540.

About Life Science Intelligence

Life Science Intelligence (LSI) delivers high quality market data and information to medical technology executives, entrepreneurs and investors. LSI produces the Emerging Medical Technology Database and provides custom research services including market assessments and physician surveys. In addition, the company partners with top tier information and consulting companies to distribute other high end information products. Learn more at www.lifescienceintelligence.com

About InteLab Corporation

InteLab Corporation has served the needs of clients in the medical device and diagnostics industry worldwide since 1991. The company has published market studies covering numerous topics in the medical device and diagnostics industry, and has also performed proprietary market and technology assessments for a wide variety of medical product manufacturers worldwide.